Headache Disability Questionnaire: cross-cultural adaptation and validation of the Turkish version.

IF 2.2 3区医学 Q3 CLINICAL NEUROLOGY BMC Neurology Pub Date : 2024-12-18 DOI:10.1186/s12883-024-03987-4

Halime Arikan

{"title":"Headache Disability Questionnaire: cross-cultural adaptation and validation of the Turkish version.","authors":"Halime Arikan","doi":"10.1186/s12883-024-03987-4","DOIUrl":null,"url":null,"abstract":"Background: The Headache Disability Questionnaire (HDQ) evaluates pain intensity, daily activities, work/school disruptions, and the impact on recreational activities. It was aimed to translate the HDQ into Turkish and evaluate its reliability and validity.Methods: This study included 130 participants, consisting of 105 females and 25 males. The original HDQ was translated into Turkish language using Beaton guidelines. Reliability was assessed using internal consistency and Intraclass Correlation Coefficient. Exploratory (EFA) and Confirmatory Factor Analysis (CFA) were conducted to evaluate the structural validity. For convergent validity, the Turkish version of the HDQ, along with the Headache Impact Test-6 (HIT-6) and Migraine Disability Assessment Scale (MIDAS), was administered to individuals with headaches. The HDQ was retested one week later to assess its reliability.Results: The Turkish version of the HDQ demonstrated good reliability, with ICC and Cronbach's α values of 0.842 and 0.914, respectively. Standard error measurement (SEM) and Minimal Detectable Change (MDC) values were 5.89 and 16.33 units. Bland-Altman plots confirmed a high level of agreement between initial and retest scores EFA revealed a two-factor structure, clustering items into Factor 1 (items 1, 2, 5, 7, and 9) and Factor 2 (items 3, 4, 6, and 8), which was subsequently confirmed by CFA. Convergent validity was confirmed through good correlations with HIT-6, and MIDAS. No ceiling or floor effects were observed.Conclusions: The study demonstrates that the Turkish version of the HDQ is a valid and reliable instrument for evaluating the effect of headaches on daily living, exhibiting strong internal consistency and test-retest reliability, making it suitable for both clinical practice and research purposes.Trial registration: Trial registration date is January 30, 2021 (NCT04736654).Clinical trials registration number: NCT04736654.","PeriodicalId":9170,"journal":{"name":"BMC Neurology","volume":"24 1","pages":"480"},"PeriodicalIF":2.2000,"publicationDate":"2024-12-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11653914/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"BMC Neurology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1186/s12883-024-03987-4","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

Background: The Headache Disability Questionnaire (HDQ) evaluates pain intensity, daily activities, work/school disruptions, and the impact on recreational activities. It was aimed to translate the HDQ into Turkish and evaluate its reliability and validity.

Methods: This study included 130 participants, consisting of 105 females and 25 males. The original HDQ was translated into Turkish language using Beaton guidelines. Reliability was assessed using internal consistency and Intraclass Correlation Coefficient. Exploratory (EFA) and Confirmatory Factor Analysis (CFA) were conducted to evaluate the structural validity. For convergent validity, the Turkish version of the HDQ, along with the Headache Impact Test-6 (HIT-6) and Migraine Disability Assessment Scale (MIDAS), was administered to individuals with headaches. The HDQ was retested one week later to assess its reliability.

Results: The Turkish version of the HDQ demonstrated good reliability, with ICC and Cronbach's α values of 0.842 and 0.914, respectively. Standard error measurement (SEM) and Minimal Detectable Change (MDC) values were 5.89 and 16.33 units. Bland-Altman plots confirmed a high level of agreement between initial and retest scores EFA revealed a two-factor structure, clustering items into Factor 1 (items 1, 2, 5, 7, and 9) and Factor 2 (items 3, 4, 6, and 8), which was subsequently confirmed by CFA. Convergent validity was confirmed through good correlations with HIT-6, and MIDAS. No ceiling or floor effects were observed.

Conclusions: The study demonstrates that the Turkish version of the HDQ is a valid and reliable instrument for evaluating the effect of headaches on daily living, exhibiting strong internal consistency and test-retest reliability, making it suitable for both clinical practice and research purposes.

Trial registration: Trial registration date is January 30, 2021 (NCT04736654).

Clinical trials registration number: NCT04736654.

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

头痛残疾问卷：土耳其语版本的跨文化适应和验证。

背景：头痛残疾问卷（HDQ）评估疼痛强度、日常活动、工作/学习中断以及对娱乐活动的影响。其目的是将HDQ翻译成土耳其语并评估其可靠性和有效性。方法：本研究共纳入130名受试者，其中女性105人，男性25人。最初的HDQ是使用比顿指南翻译成土耳其语的。信度评估采用内部一致性和类内相关系数。采用探索性（EFA）和验证性因子分析（CFA）来评估结构效度。为了收敛效度，土耳其版的HDQ，以及头痛影响测试-6 （HIT-6）和偏头痛残疾评估量表（MIDAS），被用于头痛患者。一周后对HDQ进行了重新测试，以评估其可靠性。结果：土耳其版HDQ具有良好的信度，ICC值为0.842,Cronbach’s α值为0.914。标准误差测量（SEM）和最小可检测变化（MDC）值分别为5.89和16.33个单位。Bland-Altman图证实了初试和复试成绩之间的高度一致性，EFA显示了一个双因素结构，将项目聚类为因素1（项目1、2、5、7和9）和因素2（项目3、4、6和8），随后由CFA证实。通过HIT-6和MIDAS的良好相关性证实了收敛效度。没有观察到天花板或地板效应。结论：本研究表明土耳其版HDQ是一种有效可靠的评估头痛对日常生活影响的工具，具有较强的内部一致性和重测信度，适合临床实践和研究目的。试验注册：试验注册日期为2021年1月30日（NCT04736654）。临床试验注册号：NCT04736654。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊

BMC Neurology 医学-临床神经学

CiteScore

4.20

自引率

0.00%

发文量

428

审稿时长

3-8 weeks

期刊介绍： BMC Neurology is an open access, peer-reviewed journal that considers articles on all aspects of the prevention, diagnosis and management of neurological disorders, as well as related molecular genetics, pathophysiology, and epidemiology.